As the population ages, more elderly patients require radiotherapy-based treatment for their pelvic malignancies, including muscle-invasive bladder cancer, as they are unfit for major surgery. Therefore, there is an urgent need to find radiosensitising agents...
In a new paper, summarized in a short talk by the University of Hull, at the Association for Radiation Research, Xstrahl’s medical systems have been used to test the effects of clinical treatments on a new PEEK device to allow ex vivo treatment regimens of samples,...
The governor of the Astrakhan region Alexander Zhilkin visited the oncology dispensary, where the newest equipment appeared, which allows treating a disease widespread in the hot Astrakhan climate - skin cancer. Skin cancer ranks first among all malignant neoplasms in...
BACKGROUND AND PURPOSE: High-precision radiotherapy (RT) requires precise positioning, particularly with high single doses. Fiducial markers in combination with onboard imaging are excellent tools to support this. The purpose of this study is to establish a pancreatic...
PURPOSE: Despite recent advances in the treatment of metastatic prostate cancer, survival rates are low and treatment options are limited to chemotherapy and hormonal therapy. Although ionizing radiation is used to treat localized and metastatic prostate cancer, the...
Purpose To assess the impact of hypoxia exposure on cellular radiation sensitivity and survival of tumor cells with diverse intrinsic radiation sensitivity under normoxic conditions. Materials and methods Three squamous cell carcinoma (SCC) cell lines, with pronounced...
Xstrahl Inc attended the AAPM annual meeting and exhibition this year in Denver, Colorado. As always, the conference included the sumbission of a series of radiation papers, many of which included Xstrahl and its SARRP platform. BEST IN PHYSICS (THERAPY): Influence of...
Despite both clinical and pre-clinical technological advancements, a lack of effective treatment for patients with primary brain tumors and those originating from metastasis remains. With the 5-year survival rate of patients experiencing primary glioblastoma...
At the 15th biannual International Wolfsberg Meeting Series in June, Xstrahl had the honour of once again sponsoring the Adrian C. Begg award, presented to the author of the highest scoring poster in the young investigator category who has proven they can perform...
Contact Us